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ABSTRACT  A study has been made of the N-terminal amino acid  pattern of 
human plasma proteins under normal and pathological conditions. The normal 
pattern shows  the following N-terminal amino acids in  order of diminishing 
quantifies: aspartic acid, glutamic acid, valine, alanine, tyrosine, leucines, and 
glycine. In healthy individuals this pattern is qualitatively stable with moderate 
quantitative  differences  between  individuals.  On  the  other  hand  radical 
quantitative  changes in  the  pattern  have  been  observed under pathological 
conditions. 
Present  classification  of  plasma  proteins  rests  almost  entirely  on  physico- 
chemical  properties;  i.e.,  electrophoretic  mobility  and  sedimentation  rate. 
This is a  natural consequence of the fact that until recently only the physico- 
chemical  methods  were  sufficiently perfected  to  offer  a  useful  means  of 
classification. However, the advent of powerful methods for the study of the 
primary protein  structure has  opened  up  new possibilities.  Thus  it  is  now 
entirely feasible  to  identify a  protein  through  a  certain  structural  feature, 
e.g.  a  terminal  amino  acid  sequence,  or  less  rigorously,  a  terminal  amino 
acid(s). This approach is not restricted, to individual proteins since it should 
also  be  possible  to  characterize a  mixture  of proteins  by  the  quantitative 
composition of, for example,  their  N-texminal amino acids.  The purpose of 
the present communication is to demonstrate the application of this principle 
to  a  natural  mixture  of proteins,  namely the  plasma  proteins.  For  the  N- 
terminal determinations we have used the phenylisothiocyanate  method  (1) 
since it is well suited for quantitative evaluation. 
A preliminary account of this work has been published (2). Simultaneously 
another  group  of workers has  produced  a  preliminary report  on  the  same 
subject (3). 
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EXPERIMENTAL 
Materials 
Commercial grade solvents were rectified as follows: Pyridine was dried over KOH 
and  distilled  (b.p.  114-116°).  Benzene  (6  volumes)  was  shaken  repeatedly  with 
concentrated H2SO4 (1  volume), washed with distilled water, dried over KOH, and 
distilled  (b.p.  79-80°).  Methylethyl ketone was  refluxed with  solid  KMnO4,  dried 
over anhydrous  K2CO8,  and  distilled  (b.p.  79-80°).  Ethyl acetate  (l  volume) was 
washed  with  5  per  cent  (w/v)  aqueous  NasCO3  (l  volume),  then  with  saturated 
CaCI2  solution,  dried  over  anhydrous  K2CO3,  and  distilled  (b.p.  77°).  Ethylene 
chloride (6 volumes) was shaken twice with concentrated H2SO4 (1 volume), washed 
consecutively with distilled water, 5 per cent (w/v) aqueous Na2CO3, distilled water, 
and  finally dried  over anhydrous  K2CO3 and  distilled  (b.p.  83-84°).  Ethanol,  96 
per cent, was once distilled and free of ultraviolet absorption. Acetic acid was of the 
A.R. grade (The British Drug Houses Ltd.). Water was glass-distilled. 
Phenylisothiocyanate  was  distilled  once in vacuo (b.p.  95°/12 ram)  and stored  in 
the cold. After long storage it turned slightly yellowish, and was then redistilled. 
N-Allylpiperidine was synthesized according to Menshutkin  (5). 
The syntheses of the PTH-amino acids  1 have been described earlier (4). 
Methods 
aLOOD SAMPLING  Twenty-four ml  samples  were drawn  from the cubital  vein 
and mixed in  the syringe with 6 ml of 3.8 per cent (w/v) sodium citrate. The cells 
were centrifuged off at 3,500 RP~ in an angle centrifuge, and the plasma immediately 
frozen and stored at --30 ° until used. The cell volume was determined by the hemato- 
crit. 
PREPARATION OF THE PTC-PROTEINS  The coupling of the plasma proteins with 
phenylisothiocyanate  was  carried  out in  aqueous  pyridine at  pH  9.  A  buffer with 
good capacity in this region was sought in order to obviate the need for pH adjust- 
ments  during  the reaction.  It was  found  that  the  buffer system N-allylpiperidine" 
acetic acid fulfilled this requirement. 
A stock solution of the buffer was made up in the following way. A  0.2 ~  solution 
of N-allylpiperidine in pyridine was prepared. An aliquot of this solution was mixed 
with an equal volume of plasma, and the amount of acetic acid required to bring the 
pH to 9.0 was determined. A corresponding amount of acetic acid was then added to 
the N-allylpiperidine solution. 
Six ml of plasma was transferred to a  50 ml centrifuge tube  (Pyrex glass),  mixed 
with an equal volume of buffer solution, and 0.2 ml of phenylisothiocyanate added. 
The tube was covered with aluminium foil, and left in a water bath at 40  ° for 1 hour, 
1  The following abbreviations have been used; PTH for 3-phenyl-2-thiohydantoin, and  PTC for 
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The phenylisothiocyanate  was gradually brought into solution by occasional gentle 
rotations of the tube. 
The reaction mixture was subsequently extracted three times with 12 ml of benzene 
and  the extracts discarded.  Troublesome emulsions were broken by centrifugation. 
The pH of the remaining aqueous phase was adjusted to 4.7 by the addition of N-acetic 
acid. Then followed three consecutive extractions with 30 ml of methylethyl ketone 
with  centrifugation after each extraction and  disposal  of the extracts.  The semidry 
protein precipitate was  now stirred up in 5  ml of water,  and this suspension again 
extracted with  methylethyl ketone  as  described.  This  resuspension  and  extraction 
procedure was repeated once more. The precipitate was finally extracted with 12 ml 
of ethanol, and centrifuged and the extract discarded. The residue was dried, first in 
a  gentle stream of air and finally for 0.5 hour in vacuo. 
HYDROLYSIS  OF  THE  PTC-PROTEINS  AND  EXTRACTION  OF  THE  PTH$  The prepara- 
tion resulting from the preceding operation was  ground into a  fine powder with  a 
glass rod. Five ml of N-HCI were added, and the tube left in an oil bath at  100 ° for 
1 hour. A  "cold finger" was used to minimize evaporation. 
The  hydrolysate  was  extracted  three  times  with  6  ml  of  ethyl  acetate.  The 
extracts were combined in a widemouthed test tube, washed with an equal volume of 
distilled water,  and evaporated with slight heating  (not above 40  °  )  in an air jet to 
2 to 3 ml. The solution was transferred to a  4 ml tube with a  tapered tip and evapo- 
rated to dryness without heat. 
ESTIMATION  OF THE PTHS BY PAPER  CHROMATOGRAPHY  This technique has been 
described earlier (6), and only its adaptation to the present purpose will be described. 
Only the solvent systems D  and F were used. Chromatography in solvent system F 
was performed in the following way. The sample to be analyzed was dissolved in 200 
/zl of acetic acid, and quantities of 5,  20,  and 40 #1 were applied to the paper.  The 
reference solution contained: 0.9 mg PTH-aspartic acid,  1.1 mg PTH-glutamlc acid, 
0.4 mg  PTH-tyrosine, 0.3  mg  PTH-glycine, and  0.5 mg  PTH-alanine per  1 ml of 
acetic acid; 20 #1 of this solution was applied. One lane was left empty for the blank. 
For chromatography in solvent system D  the remainder of the sample solution was 
evaporated to dryness in an air jet, redissolved in 40/zl of ethylene chloride, and  15 
ktl of this solution applied to the paper.  The reason for this change of solvent is that 
the  acetic  acid  disturbs  the  chromatography  by dissolving  out the formamide im- 
pregnation  at  the  point  of application.  The  reference solution  contained:  0.7  mg 
PTH-glycine, 0.8 mg  PTH-alanine,  1.0 mg  PTH-valine,  and  0.5  mg  PTH-leucine 
per  1 ml  of ethylene chloride;  15  #1  of this  solution was  applied.  An  empty lane 
served as a  blank. 
After completion of the chromatography the papers were dried at room temperature 
in a  stream of air. Using the fluorescent screen (6) as a  guide the spots were cut out 
together with  areas  of corresponding size and level from the  blank lanes.  The cut 
out pieces were eluted with  1.5 ml of 70 per cent aqueous ethanol overnight. 
Spectrophotometric readings were made at the wave length 269 m/z. All extinctions 
were corrected for the background absorption of the paper. The unknowns were also 
corrected for  chromatographic  losses.  The  correction factor,  C1,  was  the  quotient 
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spot. The expected extinction was calculated from the molar extinction of the appro- 
priate  PTH  (7).  In  general  these  corrections were  small  in  system  F,  somewhat 
larger  in  system  D,  and  particularly  for  PTH-leucines,  when  chromatographic 
losses  of 30 per cent and more were common. 
PTH-alanine, and occasionally PTH-glycine, could be determined in both solvent 
systems. However, the PTH-glycine spot in system D was usually not sufficiently well 
separated  from the  ultraviolet-absorbing material  at  the  origin  to  allow  a  reliable 
determination.  As  a  rule  the  two  independent  determinations  were  in  excellent 
agreement, and the results have been averaged. 
The chosen set of unknown and  reference samples  allowed in  most instances  the 
evaluation of an "unknown" spot against a reference spot of approximately the same 
intensity  and  this  served  to  improve  accuracy.  The  accuracy  is  estimated  to  be 
within  -4-  10 per cent for quantities above  10/zg in  a  spot,  but below that level it 
decreases  because  of the  relative  increase  in  importance  of the  blank  correction. 
The figures for PTH-tyrosine, PTH-leucines and PTH-glycine in normal plasma are 
therefore probably not more accurate than  -4-  15 per cent. 
A  final correction, C2,  was  applied for the dilution of the  plasma  by the citrate 
solution used as the anticoagulant, according to the formula: 
ioo  B  C~=I+ 
Ioo -- D  " 
where A  is  the  volume of blood sample,  B,  the volume of citrate solution,  and  D, 
the percentage cell volume. 
SPECTROPHOTOMETRIC MEASUREMENTS  These were made on a  Beckman DK-2 
quartz spectrophotometer provided with quartz absorption ceils with a  path length 
of 1 cm and a  holding volume of 1.5 ml. 
P~I MEASr_rREME~TS  These were made with a  glass electrode. 
RESULTS 
The  results of the  N-terminal  determination  of pooled plasma  are presented 
in  Table  I.  These figures can  be taken  to represent the  average  N-terminal 
amino  acid  pattern  in  a  healthy population.  Determinations  have also  been 
made  on  plasma  from healthy  individuals  in  order  to  obtain  a  measure  of 
the  normal  variation.  These  individuals  were  chosen  from  both  sexes,  and 
varied in  age from 20  to  59 years  (Table I). 
A  potential source of error in the determination of N-terminal amino acids 
in plasma is the occurrence of free amino acids in plasma, and much attention 
has  been  given  to  the  problem  of excluding  interference from  this  source. 
The  procedure  finally  adopted  was  an  exhaustive  extraction  of the  PTC- 
proteins with methylethyl ketone.  Loading experiments, in which free amino 
acids were added to blood plasma, showed that a sixfold increase of the normal 
plasma  level  of free amino  acids  did  not  affect the  results  (Table  II).  The HUGH NIALL AND PEHR EDMAN  N-Terminal Amino Acids of Human Plasma Proteins  18  9 
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figures for the normal plasma level are those of Stein and Moore  (8).  This 
level is  believed  to  vary little  under physiological and  pathological condi- 
tions,  and  our procedure should therefore offer a  reasonable safety margin 
against contamination from free amino acids. 
The  simplified version  of the phenylisothiocyanate method employed in 
this  investigation  did  not  allow  the  determination  of  certain  N-terminal 
amino acids.  Thus, in the acid hydrolysis of the PTC-proteins the PTH de- 
rivatives  of serine,  threonine,  cysteine,  and  tryptophan are  destroyed,  and 
the derivatives of asparagine and glutamine are  converted to  PTH-aspartic 
TABLE  II 
THE EFFECT OF ADDING FREE AMINO ACIDS TO 
PLASMA ON N-TERMINAL DETERMINATIONS 
Concentration of N-terminal amino  acid 
PTH-amlno  acid  Unloaded  Loaded* 
Izg PTH/ml  izg PTH/ml 
Aspartic  acid  110  106 
Glutamie acid  49  50 
Valine  10.1  12.5 
Alanine  10.4  10.5 
Tyrosine  5.4  6.7 
Leucines  11.2  10.1 
Glycine  4.6  5.7 
* The load of free amino acids per milliliter of plasma was 26/~g  asparagine; 490 #g glutamine; 
149 #g valine; 42 #g phenylalanine; 177 #g alanine; 56 #g tyrosine; 128 #g leucine; 75 #g glycine. 
acid  and  PTH-glutamic acid.  Further,  no attempt was made to determine 
arginine and histidine, although this might have been possible. Uncertainties 
also arise from the fact that certain pairs of PTH-amino acids partly overlap 
in  the  paper  chromatograms and  small  amounts  of one  amino  acid  may 
therefore have escaped notice in the presence of a large amount of the other. 
This applies to the pairs valine-phenylalanine and leucine-isoleucine. 
Our  figures  are  probably  somewhat too  low,  as  no  correction for  losses 
during hydrolysis has been made.  Such correction is  difficult to make,  but 
since  PTHs  are  quite  stable  to  dilute  aqueous  acids,  with  the  exceptions 
mentioned above, it is certain to be small. 
DISCUSSION 
The  N-terminal  amino  acids  already  reported  for  various  plasma  protein 
fractions  (Table  III)  are  all  represented  in  the  over-aU  pattern  with  the 
exception of serine and  threonine. The latter amino acids are not included 
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Our results and those of SjSquist et al.  (3) are generally found to be in good 
agreement when recalculated to a  common basis. A  notable exception how- 
ever,  is  N-terminal  glutamic  acid,  where our  figure is  two  to  three  times 
higher.  No explanation for  this  discrepancy can be  offered at present.  On 
the other hand, the absence of N-terminal tyrosine in the analysis of SjSquist 
and coworkers is probably explained by the fact that they used blood serum, 
since it is known that tyrosine is N-terminal in human fibrinogen (20,  21). 
The  pathological N-terminal  amino  acid patterns  (Fig.  1)  do  not allow 
much comment at present. However, it should be obvious that the N-terminal 
pattern is a very sensitive index of changes in the plasma protein composition 
TABLE  III 
N-TERMINAL  AMINO  ACIDS  IN  HUMAN 
PLASMA  PROTEIN  FRACTIONS 
Plasma protein fraction  N-terminal amino acid  Reference 
Albumin  Aspartic acid  9--11 
Lipoprotein  12-14 
D  -~  1.149  Aspartic acid 
D  =  1.093  Aspartic acid 
D  --  1.029  Glutamic acid 
D  =  1.002-1.006  Serine and threonine 
Transferrin  Valine  15 
Ba-a2-glycoprotein  Alanine and threonine  16 
-r-Globulin  Aspartic acid,  glutamic acid,  and serine  17-19 
Fibrinogen  Tyrosine and alanine  20, 21 
Haptoglobin  Valine and isoleucin~  22 
in disease. Diagnostic and other implications of these observations remain to 
be investigated. 
Finally  a  comment  should  be  made  on  the  principle  of characterizing 
plasma  proteins  through details of their primary structures.  Its  main merit 
lies in the fact that it utilizes an invariant property of the protein molecule. 
This is in contrast to the physicochemical characterization  where the mag- 
nitude of the parameters  measured is dependent on experimental variables; 
i.e.,  hydrogen  ion  concentration,  ionic  strength,  temperature,  and  so  on. 
Further, secondary modifications of the protein molecule, e.g.  through poly- 
merization or  adsorption of non-protein material,  are less  likely to  involve 
the  structural  detail  used  for  the  characterization.  Generic  relationships 
between plasma proteins should therefore be more easily recognizable. 
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FIGURE  1.  N-terminal amino acid pattern of plasma proteins in individuals in various 
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